Stock BPLPHARMA6 BHARAT PARENTERALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Bharat Parenterals Limited

Equities

BPLPHARMA6

INE365Y01019

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 10:45:55 26/06/2024 am IST 		5-day change 1st Jan Change
1,475 INR -2.50% Intraday chart for Bharat Parenterals Limited +5.31% +82.08%
24/06 Bharat Parenterals Limited agreed to acquire an unknown majority stake in Varenyam Biolifesciences Private Limited for INR 22.56 million. CI
06/06 Bharat Parenterals to Raise Stake in Subsidiary Innoxel Lifesciences MT

Business Summary

Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies.

Number of employees: 363

Sales per Business

INR in Million2023Weight2024Weight Delta
Pharmaceuticals Formulations
98.6 %
2,180 100.0 % 2,537 98.6 % +16.40%
Services
1.3 %
- - 32 1.3 % -
Other
0.2 %
- - 4 0.2 % -

Sales per region

INR in Million2023Weight2024Weight Delta
International
62.5 %
1,086 49.9 % 1,607 62.5 % +47.89%
India
37.5 %
1,089 50.1 % 963 37.5 % -11.55%

Managers

Managers TitleAgeSince
Bharatkumar R. Desai CEO
 Chief Executive Officer 61 03/92/03
Jignesh Nitinchandra Shah DFI
 Director of Finance/CFO - 14/18/14
Krutika Padmakar Bhattbhatt CMP
 Compliance Officer - 02/23/02
Nikita Desai SAM
 Sales & Marketing - -
Bhahim Bharatkumar Desai PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Bharatkumar R. Desai CEO
 Chief Executive Officer 61 03/92/03
Hemang Jayendrabhai Shah BRD
 Director/Board Member 55 08/10/08
Shailesh Kumar Gabhawala BRD
 Director/Board Member 60 03/17/03
Zankhana Sheth BRD
 Director/Board Member 58 14/18/14
Mukeshbhai Patel BRD
 Director/Board Member 55 26/20/26
Sanjay Parasmal Shah BRD
 Director/Board Member 46 02/20/02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,524,447 2,260,667 ( 34.65 %) 0 34.65 %

Shareholders

NameEquities%Valuation
Desai Shares & Stock Pvt Ltd.
46.94 %
2,731,536 46.94 % 44 M ₹
Hima B. Desai
13.46 %
783,430 13.46 % 13 M ₹
Bharatkumar R. Desai
12.74 %
741,515 12.74 % 12 M ₹

Company contact information

Bharat Parenterals Ltd.

144-146VILL Haripura Ta Savli Jarod Samlaya Road

391520, Vadodara

+91 26 6725 1679

http://www.bplindia.in
address Bharat Parenterals Limited(BPLPHARMA6)

Group companies

NameCategory and Sector
Innoxel Lifesciences Pvt Ltd.
Logo Innoxel Lifesciences Pvt Ltd.

Innoxel Lifesciences Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Innoxel Lifesciences Pvt Ltd. engages in the manufacture of chemicals and chemical products activities. The company is headquartered in Vadodara, India.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
BHARAT PARENTERALS LIMITED Stock Bharat Parenterals Limited
+82.08% 118M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.19% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+47.26% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.09% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.92% 337B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.40% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+3.64% 229B
NOVARTIS AG Stock Novartis AG
+12.98% 219B
AMGEN INC. Stock Amgen Inc.
+10.86% 171B
PFIZER, INC. Stock Pfizer, Inc.
-2.78% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BPLPHARMA6 Stock
  4. Company Bharat Parenterals Limited